1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Allakos Inc.
  6. News
  7. Summary
    ALLK   US01671P1003

ALLAKOS INC.

(ALLK)
  Report
Delayed Nasdaq  -  05/17 04:00:01 pm EDT
3.280 USD   +2.82%
05/11Barclays Adjusts Allakos' Price Target to $2.50 from $7, Keeps Underweight Rating
MT
05/09Morgan Stanley Adjusts Price Target for Allakos to $6 From $8, Maintains Equalweight Rating
MT
05/09Allakos Provides Business Update and Reports First Quarter 2022 Financial Results
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Paychex, Tesla rise; CalAmp, Allakos fall

12/22/2021 | 04:17pm EDT

Stocks that traded heavily or had substantial price changes Wednesday:

Allakos Inc., down $75.84 to $8.55.

Investors were disappointed with the biotechnology company's latest update on its drug development program.

CalAmp Corp., down $2.55 to $7.34.

The wireless communications company reported disappointing third-quarter financial results.

AAR Corp., up 90 cents to $38.05.

The airplane maintenance company announced a $150 million stock buyback program.

Lennar Corp., up $3.63 to $112.35.

Homebuilders gained ground following a report that showed home sales rose for a third straight month.

Paychex Inc., up $6.98 to $133.41.

The payroll processor and human-resources services provider beat analysts' fiscal second-quarter profit forecasts.

Devon Energy Corp., up 98 cents to $42.29.

Energy stocks gained ground on rising natural gas and oil prices.

Whirlpool Corp., up $2.95 to $224.33.

A wide range of consumer-focused companies gained ground following an encouraging report on consumer confidence.

Tesla Inc., up $70.34 to $1,008.87.

CEO Elon Musk reportedly said he sold enough stock to reach his goal of selling 10% of his stake in the electric vehicle maker.

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

Stocks mentioned in the article
ChangeLast1st jan.
ALLAKOS INC. 2.82% 3.28 Delayed Quote.-66.50%
CALAMP CORP. 2.71% 5.69 Delayed Quote.-21.53%
PAYCHEX, INC. 1.30% 121.62 Delayed Quote.-10.90%
TESLA, INC. 5.14% 761.61 Delayed Quote.-27.93%
All news about ALLAKOS INC.
05/11Barclays Adjusts Allakos' Price Target to $2.50 from $7, Keeps Underweight Rating
MT
05/09Morgan Stanley Adjusts Price Target for Allakos to $6 From $8, Maintains Equalweight Ra..
MT
05/09Allakos Provides Business Update and Reports First Quarter 2022 Financial Results
AQ
05/09Allakos Files for Potential Offering of Up to $250 Million of Common Shares
MT
05/06Allakos Q1 Loss Widens from Year Ago -- Stock Down Near 3% After-Hours
MT
05/06ALLAKOS INC. Management's Discussion and Analysis of Financial Condition and Results o..
AQ
05/06Allakos Provides Business Update and Reports First Quarter 2022 Financial Results
GL
05/06Allakos Provides Business Update and Reports First Quarter 2022 Financial Results
AQ
05/06Allakos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/20ALLAKOS INC. : Change in Directors or Principal Officers, Financial Statements and Exhibit..
AQ
More news
Analyst Recommendations on ALLAKOS INC.
More recommendations
Financials (USD)
Sales 2022 - - -
Net income 2022 -310 M - -
Net cash 2022 126 M - -
P/E ratio 2022 -0,58x
Yield 2022 -
Capitalization 180 M 180 M -
EV / Sales 2022 -
EV / Sales 2023 -
Nbr of Employees 192
Free-Float 93,7%
Chart ALLAKOS INC.
Duration : Period :
Allakos Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ALLAKOS INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Last Close Price 3,28 $
Average target price 9,94 $
Spread / Average Target 203%
EPS Revisions
Managers and Directors
Robert Alexander Chief Executive Officer & Director
Adam L. Tomasi President & Chief Operating Officer
Harlan Baird Radford Chief Financial Officer
Daniel S. Janney Chairman
Ruby Casareno Vice President-Technical Operations
Sector and Competitors
1st jan.Capi. (M$)
ALLAKOS INC.-66.50%180
GILEAD SCIENCES, INC.-12.99%79 248
REGENERON PHARMACEUTICALS, INC.5.71%71 927
VERTEX PHARMACEUTICALS19.24%66 967
WUXI APPTEC CO., LTD.-16.20%42 682
BIONTECH SE-38.01%38 834